Personalised care planning gives better T2D control 

The drive towards personalised care continues with the development of new software called the Healum app. Results of an 18-month trial presented at the Diabetes UK professional conference in March showed people who used it had an average 9.5% reduction in HbA1c blood glucose compared with 2% reduction in a comparable control group.A key challenge in long-term condition management is to motivate and support patients to make healthy choices and understand how to best manage their diabetes in a way that means something to them,” said Dr. Adrian Heald, a diabetes specialist from Salford Royal Hospital, who led the National Institute of Health Research-funded study in Manchester. The app has so far been trialled in just 36 volunteers and the aim is now to collect data from a further 214 people to see how it can best be adjusted and refined. 

The app has been developed by the co-founders of Healum, Anuj Saboo and Jonathan Abraham. They worked collaboratively with diabetes clinicians throughout the project, helping to inform the design of the product so it can work as a truly assistive technology to make doctors lives easier, and improve outcomes for patients.

For more info on the trial, CLICK HERE.


Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags